Results 41 to 50 of about 5,871 (171)

MEDICAL METHODS OF CORRECTION OF RENAL OSTEODYSTROPHY

Остеопороз и остеопатии, 2014
The article presents a literature review summarizing the contemporary data on the effects of drug therapy on various parameters of renal osteodystrophy: phosphate binders, vitamin D preparations, bisphosphonates, denosumab, and calcimimetics.
L V Egshatyan, L Ya Rozhinskaya
doaj   +1 more source

Osteosarcopenia in Chronic Kidney Disease: An Overlooked Syndrome?

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 2, April 2025.
ABSTRACT Background Healthy ageing relies on maintaining physiological systems, particularly the musculoskeletal system (MKS). After 50, declines in bone density, muscle mass and strength increase the risk of osteoporosis and sarcopenia, leading to frailty, fractures and higher healthcare costs.
Lara Caldiroli, Paolo Molinari, Claudia D'Alessandro, Adamasco Cupisti, Carlo Alfieri, Giuseppe Castellano, Simone Vettoretti   +6 more
wiley   +1 more source

Vitamin D Deficiency in Children with Chronic Kidney Disease [PDF]

Journal of Clinical and Diagnostic Research, 2019
Introduction: Vitamin D deficiency leads to defective mineralisation and in Chronic Kidney Disease (CKD) can contribute to renal osteodystrophy. Aim: To compare the serum level of vitamin D in children with CKD as compared to those with normal condition.
Nasrin Esfandiar, Marjan Shakiba, Zahra Mirzaei   +2 more
doaj   +1 more source

Assessment of Vertebral Bone Marrow Perfusion, Fat/Water Content, and Trabecular Bone Changes Using Multimodal MRI and Micro‐CT in a Rat Model of Chronic Kidney Disease

JOR SPINE, Volume 8, Issue 1, March 2025.
To examine pathophysiological changes in vertebral bone marrow associated with chronic kidney disease using various imaging techniques. ABSTRACT Background Disturbances in calcium and phosphorus homeostasis resulting from chronic kidney disease (CKD) may lead to atherosclerotic changes in blood vessels, potentially altering bone marrow perfusion.
Guo‐Shu Huang, Shih‐Wei Chiang, Yi‐Jen Peng, Skye Hsin‐Hsien Yeh, Yu‐Juei Hsu, Yu‐Ching Chou, Heng‐Han Chang, Herng‐Sheng Lee, Ying‐Chun Liu, Chao‐Ying Wang   +9 more
wiley   +1 more source

Proteinuria and tubular cells: Plasticity and toxicity

Acta Physiologica, Volume 241, Issue 2, February 2025.
Abstract Aim Proteinuria is the most robust predictive factors for the progression of chronic kidney disease (CKD), and interventions targeting proteinuria reduction have shown to be the most effective nephroprotective treatments to date. While glomerular dysfunction is the primary source of proteinuria, its consequences extend beyond the glomerulus ...
Anna Faivre, Thomas Verissimo, Sophie de Seigneux   +2 more
wiley   +1 more source

The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histological findings

São Paulo Medical Journal
INTRODUCTION: Renal osteodystrophy includes the complete range of mineral metabolism disorders that affect the skeleton in patients with chronic renal failure.
Maria Eugênia Leite Duarte, Ana Lúcia Passos Peixoto, Andréa da Silva Pacheco, Angela Vieira Peixoto, Rodrigo Dezerto Rodriguez, Jocemir Ronaldo Lugon, Elisa Albuquerque Sampaio da Cruz   +6 more
doaj   +1 more source

Bilateral spontaneous fracturing of the femoral neck in a patient with renal osteodystrophy,

Revista Brasileira de Ortopedia, 2014
We report a case of bilateral fracturing of the femoral neck in a patient with renal osteodystrophy who was treated by means of osteosynthesis. In this type of patient, there is a need to remain watchful for the possibility of occurrences of spontaneous ...
Flavio Luís Garcia, Renato Bellini Dalio, Arthur Tomotaka Sugo, Celso Hermínio Ferraz Picado   +3 more
doaj   +1 more source

Clinical features of low serum alkaline phosphatase levels in children: A retrospective study

Pediatrics International, Volume 67, Issue 1, January/December 2025.
Abstract Background Serum alkaline phosphatase (ALP), a biomarker of bone and liver metabolism, is often elevated in children; however, the lower reference limit is rarely considered. Hypophosphatasia (HPP) is characterized by low ALP levels and impaired mineralization of bone and teeth.
Mami Kurihara, Hanako Tajima, Ryu Ishii, Tae Matsumoto, Makoto Migita   +4 more
wiley   +1 more source

Management of renal osteodystrophy in children

The Turkish Journal of Pediatrics, 2005
Prevention and treatment of renal osteodystrophy (ROD) are great challenges for pediatric nephrologists. The strategies for prevention and treatment of ROD in children with chronic renal failure (CRF) should be created on an individual basis.
Velibor Tasic
doaj  

Pseudohypoparathyroidism Presenting With Recurrent Twitching: Challenges Making a Diagnosis in a Low‐Resource Environment

Case Reports in Endocrinology, Volume 2025, Issue 1, 2025.
Pseudohypoparathyroidism (PHP) is a metabolic disorder that occurs due to target end‐organ resistance to parathyroid hormone (PTH). It is a rare cause of severe symptomatic hypocalcemia as it characteristically manifests with high phosphate and low calcium.
Phoebe Wamalwa, Prisca Amolo, Osamu Isozaki   +2 more
wiley   +1 more source